JPRN-UMIN000003214已完成4 期
The study of having an inhibitory effect on occuring ocular surface disorders of Blokyleate PF ophthalmic solution 2% in a glaucomatous eye -Controlled trial with Mikelan ophthalmic solution 2%- - The controlled trial of Blokyleate PF ophthalmic solution 2% and Mikelan ophthalmic solution 2%
ITTEN Pharmaceutical co. ltd.0 个研究点目标入组 150 人开始时间: 2010年2月19日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •At the time of informed consent acquisition and the baseline test, a patient corresponding to any of the following criterion is excluded. 1) A patient putting contact lens on the evaluation-intended eye. 2) A patient whose best-corrected visual acuity on the evaluation-intended eye is under 0.5. 3) A patient having eye disorder except for cataract and ametropia on the evaluation-intended eye. (However, the following 4)-12) are considered.) 4) A patient complicating chronic or recurrent inflammatory disorder (uveitis, scleritis, corneal herpes, and so on) on the evaluation-intended eye. 5) A patient complicating eye disorder, such as retinal degeneration, retinopathy of diabetes, allergic conjunctival disease and so on, which is judged as ineligibility for enrollment by an investigator, on the evaluation-intended eye. 6) A patient complicating infections on the evaluation-intended eye. 7) A patient having the history of glaucoma surgery on the evaluation-intended eye. (Except for the following laser surgery which is conducted before more than 3 months (12 weeks) obtaining the informed consent.) Laser iridotomy, laser trabeculoplasty and laser angleplasty. 8) A patient having the history of intraocular surgery on the evaluation-intended eye within 3 months (12 weeks)before obtaining the informed consent. 9) A patient having the history of ophthalmologic laser surgery on the evaluation-intended eye within 3 months (12 weeks) before obtaining the informed consent. 10) A patient having the history of ocular injury on the evaluation-intended eye within 3 months (12 weeks) before obtaining the informed consent. 11) A patient having the severe kerato- conjunctiva epithelium disorder (persistent epithelial defect, corneal erosion, and so on) on the evaluation-intended eye. 12) A patient interfering with applanometry on the evaluation-intended eye. 13) A patient having carteolol hydrochloride sensitivity. Other 11 items.
研究者
相似试验
尚未招募
1 期
Exploratory Investigation of the Inhibitory Effect of Codium fragile Extract Lectin on Biofilm Formation on Human Tooth SurfaceOral Biofilm InfectionJPRN-UMIN000053076Okayama University15
已完成
Unknown
The study for the suppressive effect on the elevation of postprandial blood glucose level by intake of the food containing seaweedHealthy adultJPRN-UMIN000046715EP Mediate Co., Ltd.24
已完成
不适用
The retrospective clinical study on inhibitory effect of 0.1% brimonidine ophthalmic solution against the optic disc hemorrhageJPRN-UMIN000026406Fukui-ken Saiseikai Hospital40
已完成
不适用
Colonisation of the nasopharynx with BLIS K12 and inhibition of growth of pathogens in healthy adult volunteers.otitis mediaACTRN12619000779178BLIS technologies50
招募中
不适用
Examination of the effect of a test food on weather-related pain and autonomic imbalancechronic pain, autonomic imbalance, headachepainD059350, D001342, D006261JPRN-jRCTs041220004shida Takahiro30